The Heat-shock, or HSF1-mediated Proteotoxic Stress, Response in Cancer: from Proteomic Stability to Oncogenesis

Overview

Journal Philos Trans R Soc Lond B Biol Sci

Specialty Biology

Date 2017 Dec 6

PMID 29203710

Citations 56

Authors

Chengkai Dai

Affiliations

Soon will be listed here.

Abstract

The heat-shock, or HSF1-mediated proteotoxic stress, response (HSR/HPSR) is characterized by induction of heat-shock proteins (HSPs). As molecular chaperones, HSPs facilitate the folding, assembly, transportation and degradation of other proteins. In mammals, heat shock factor 1 (HSF1) is the master regulator of this ancient transcriptional programme. Upon proteotoxic insults, the HSR/HPSR is essential to proteome homeostasis, or proteostasis, thereby resisting stress and antagonizing protein misfolding diseases and ageing. Contrasting with these benefits, an unexpected pro-oncogenic role of the HSR/HPSR is unfolding. Whereas HSF1 remains latent in primary cells without stress, it becomes constitutively activated within malignant cells, rendering them addicted to HSF1 for their growth and survival. Highlighting the HSR/HPSR as an integral component of the oncogenic network, several key pathways governing HSF1 activation by environmental stressors are causally implicated in malignancy. Importantly, HSF1 impacts the cancer proteome systemically. By suppressing tumour-suppressive amyloidogenesis, HSF1 preserves cancer proteostasis to support the malignant state, both providing insight into how HSF1 enables tumorigenesis and suggesting disruption of cancer proteostasis as a therapeutic strategy. This review provides an overview of the role of HSF1 in oncogenesis, mechanisms underlying its constitutive activation within cancer cells and its pro-oncogenic action, as well as potential HSF1-targeting strategies.This article is part of the theme issue 'Heat shock proteins as modulators and therapeutic targets of chronic disease: an integrated perspective'.

Citing Articles

IER5 Promotes Ovarian Cancer Cell Proliferation and Peritoneal Dissemination.

Krishnaraj J, Ueno S, Nakamura M, Tabata Y, Yamamoto T, Asano Y Cancers (Basel). 2025; 17(4).

PMID: 40002205 PMC: 11853144. DOI: 10.3390/cancers17040610.

Unveiling the HSF1 Interaction Network: Key Regulators of Its Function in Cancer.

Vladimirova S, Kokoreva N, Guzhova I, Alhasan B, Margulis B, Nikotina A Cancers (Basel). 2024; 16(23).

PMID: 39682216 PMC: 11640653. DOI: 10.3390/cancers16234030.

Myriad factors and pathways influencing tumor radiotherapy resistance.

Mi L, Zhang H Open Life Sci. 2024; 19(1):20220992.

PMID: 39655194 PMC: 11627069. DOI: 10.1515/biol-2022-0992.

The Role of Heat Shock Factor 1 in Preserving Proteomic Integrity During Copper-Induced Cellular Toxicity.

Ghai S, Shrestha R, Hegazi A, Boualoy V, Liu S, Su K Int J Mol Sci. 2024; 25(21).

PMID: 39519208 PMC: 11546224. DOI: 10.3390/ijms252111657.

A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications.

Zhang X, Fan Y, Tan K Cell Death Dis. 2024; 15(9):667.

PMID: 39261452 PMC: 11390889. DOI: 10.1038/s41419-024-07049-y.

References

Su K, Cao J, Tang Z, Dai S, He Y, Sampson S . HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth. Nat Cell Biol. 2016; 18(5):527-39. PMC: 5341796. DOI: 10.1038/ncb3335. View

Wang R, Sengupta K, Li C, Kim H, Cao L, Xiao C . Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008; 14(4):312-23. PMC: 2643030. DOI: 10.1016/j.ccr.2008.09.001. View

Sato S, Fujita N, Tsuruo T . Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A. 2000; 97(20):10832-7. PMC: 27109. DOI: 10.1073/pnas.170276797. View

Nakamura Y, Fujimoto M, Fukushima S, Nakamura A, Hayashida N, Takii R . Heat shock factor 1 is required for migration and invasion of human melanoma in vitro and in vivo. Cancer Lett. 2014; 354(2):329-35. DOI: 10.1016/j.canlet.2014.08.029. View

Dai C, Whitesell L, Rogers A, Lindquist S . Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell. 2007; 130(6):1005-18. PMC: 2586609. DOI: 10.1016/j.cell.2007.07.020. View

Tang Z, Dai S, He Y, Doty R, Shultz L, Sampson S . MEK guards proteome stability and inhibits tumor-suppressive amyloidogenesis via HSF1. Cell. 2015; 160(4):729-744. PMC: 4564124. DOI: 10.1016/j.cell.2015.01.028. View

Mendillo M, Santagata S, Koeva M, Bell G, Hu R, Tamimi R . HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell. 2012; 150(3):549-62. PMC: 3438889. DOI: 10.1016/j.cell.2012.06.031. View

Nagai N, Nakai A, Nagata K . Quercetin suppresses heat shock response by down regulation of HSF1. Biochem Biophys Res Commun. 1995; 208(3):1099-105. DOI: 10.1006/bbrc.1995.1447. View

Heimberger T, Andrulis M, Riedel S, Stuhmer T, Schraud H, Beilhack A . The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma. Br J Haematol. 2012; 160(4):465-76. DOI: 10.1111/bjh.12164. View

10.

Fujimoto M, Nakai A . The heat shock factor family and adaptation to proteotoxic stress. FEBS J. 2010; 277(20):4112-25. DOI: 10.1111/j.1742-4658.2010.07827.x. View

11.

Grahame Hardie D . AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol. 2014; 33:1-7. DOI: 10.1016/j.ceb.2014.09.004. View

12.

Cox A, Fesik S, Kimmelman A, Luo J, Der C . Drugging the undruggable RAS: Mission possible?. Nat Rev Drug Discov. 2014; 13(11):828-51. PMC: 4355017. DOI: 10.1038/nrd4389. View

13.

Byles V, Zhu L, Lovaas J, Chmilewski L, Wang J, Faller D . SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene. 2012; 31(43):4619-29. PMC: 4157820. DOI: 10.1038/onc.2011.612. View

14.

Murshid A, Chou S, Prince T, Zhang Y, Bharti A, Calderwood S . Protein kinase A binds and activates heat shock factor 1. PLoS One. 2010; 5(11):e13830. PMC: 2976705. DOI: 10.1371/journal.pone.0013830. View

15.

Bubici C, Papa S . JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol. 2013; 171(1):24-37. PMC: 3874694. DOI: 10.1111/bph.12432. View

16.

Ahsan A, Ramanand S, Whitehead C, Hiniker S, Rehemtulla A, Pratt W . Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia. 2012; 14(8):670-7. PMC: 3431175. DOI: 10.1593/neo.12986. View

17.

Xi C, Hu Y, Buckhaults P, Moskophidis D, Mivechi N . Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis. J Biol Chem. 2012; 287(42):35646-35657. PMC: 3471706. DOI: 10.1074/jbc.M112.377481. View

18.

Yokota S, Kitahara M, Nagata K . Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res. 2000; 60(11):2942-8. View

19.

Jin X, Moskophidis D, Hu Y, Phillips A, Mivechi N . Heat shock factor 1 deficiency via its downstream target gene alphaB-crystallin (Hspb5) impairs p53 degradation. J Cell Biochem. 2009; 107(3):504-15. PMC: 2771697. DOI: 10.1002/jcb.22151. View

20.

Dai C, Sampson S . HSF1: Guardian of Proteostasis in Cancer. Trends Cell Biol. 2015; 26(1):17-28. PMC: 4722819. DOI: 10.1016/j.tcb.2015.10.011. View